We are live on ! Find out more
ProShare Advisors

ProShare Advisors Portfolio holdings

AUM $67.5B
1-Year Est. Return 28.09%
This Fund
S&P 500
This Quarter Est. Return
+16.25%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$26.9B
AUM Growth
+$5.25B
Cap. Flow
+$2.28B
Cap. Flow %
8.49%
Top 10 Hldgs %
25.71%
Holding
2,122
New
483
Increased
1,399
Reduced
210
Closed
29

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$148M
2
NVDA icon
NVIDIA
NVDA
+$57.1M
3
BABA icon
Alibaba
BABA
+$52.4M
4
TSLA icon
Tesla
TSLA
+$41.3M
5
STMP
Stamps.com, Inc.
STMP
+$37.6M

Sector Composition

Rank Sector Weight
1 Technology 24.73%
2 Consumer Discretionary 15.7%
3 Industrials 10.47%
4 Communication Services 9.84%
5 Healthcare 9.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
P
1701
Everpure Inc
P
$24.8B
$262K ﹤0.01%
11,584
+991
+9% +$19K
AXTA icon
1702
Axalta
AXTA
$7.01B
$261K ﹤0.01%
+9,158
New +$249K
ELAN icon
1703
Elanco Animal Health
ELAN
$12.4B
$261K ﹤0.01%
+8,521
New +$260K
ESPR
1704
DELISTED
Esperion Therapeutics
ESPR
$261K ﹤0.01%
10,035
+2,380
+31% +$71.3K
AVTR icon
1705
Avantor
AVTR
$7.81B
$260K ﹤0.01%
+9,247
New +$238K
PTGX icon
1706
Protagonist Therapeutics
PTGX
$8.75B
$260K ﹤0.01%
+12,875
New +$277K
VRE
1707
DELISTED
Veris Residential
VRE
$260K ﹤0.01%
20,886
+8,684
+71% +$111K
ARCB icon
1708
ArcBest
ARCB
$3.44B
$259K ﹤0.01%
+6,070
New +$231K
CHCO icon
1709
City Holding Co
CHCO
$1.97B
$259K ﹤0.01%
+3,722
New +$241K
COLL icon
1710
Collegium Pharmaceutical
COLL
$1.14B
$259K ﹤0.01%
12,943
+3,171
+32% +$61.9K
IPAR icon
1711
Interparfums
IPAR
$3.92B
$259K ﹤0.01%
+4,275
New +$215K
OXM icon
1712
Oxford Industries
OXM
$577M
$259K ﹤0.01%
+3,957
New +$205K
PBI icon
1713
Pitney Bowes
PBI
$2.42B
$259K ﹤0.01%
42,014
+17,369
+70% +$104K
SCS
1714
DELISTED
Steelcase
SCS
$259K ﹤0.01%
19,115
+8,540
+81% +$105K
EB
1715
DELISTED
Eventbrite
EB
$258K ﹤0.01%
+14,242
New +$199K
SI
1716
DELISTED
Silvergate Capital Corporation
SI
$258K ﹤0.01%
+3,469
New +$114K
SAFE
1717
Safehold
SAFE
$1.19B
$257K ﹤0.01%
3,559
+1,444
+68% +$94K
KEX icon
1718
Kirby Corp
KEX
$7.95B
$256K ﹤0.01%
+4,947
New +$225K
LASR icon
1719
nLIGHT
LASR
$3.95B
$255K ﹤0.01%
+7,814
New +$221K
HCM icon
1720
HUTCHMED
HCM
$1.89B
$254K ﹤0.01%
7,947
+35
+0.4% +$1.08K
TVRD
1721
Tvardi Therapeutics
TVRD
$23.5M
$254K ﹤0.01%
467
+117
+33% +$61.3K
CHCT
1722
Community Healthcare Trust
CHCT
$537M
$253K ﹤0.01%
+5,361
New +$255K
PEGA icon
1723
Pegasystems
PEGA
$4.41B
$253K ﹤0.01%
3,792
+294
+8% +$18.8K
CERS icon
1724
Cerus
CERS
$587M
$252K ﹤0.01%
36,374
-10,532
-22% -$69.1K
CHH icon
1725
Choice Hotels
CHH
$5.03B
$252K ﹤0.01%
+2,365
New +$230K

Similar funds

ProShare Advisors's Q4 2020 Portfolio in Review

As of Q4 2020, ProShare Advisors held 2,122 positions worth $26.9B, up 24% from $21.6B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

ProShare Advisors deployed $2.28B of net new capital in Q4 2020, opening 483 new positions and adding to 1,399 existing holdings. Its largest new stake was Keurig Dr Pepper: 1,170,659 shares worth $37.5M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 25% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $32.9M trimmed.

  • ProShare Advisors's largest Q4 2020 buy was Keurig Dr Pepper: 1,170,659 shares worth $37.5M.
  • ProShare Advisors added most to Amazon in Q4 2020, an estimated $148M increase.
  • ProShare Advisors's biggest Q4 2020 reduction was Alphabet (Google) Class A, cutting an estimated $32.9M.
  • ProShare Advisors fully exited The Aaron's Company Inc Class A in Q4 2020, selling an estimated $26.2M.
  • ProShare Advisors's ten largest holdings make up 26% of its $26.9B portfolio in Q4 2020.
  • ProShare Advisors opened 483 new positions and closed 29 in Q4 2020.
  • ProShare Advisors's portfolio value rose 24% quarter-over-quarter to $26.9B.

Based on ProShare Advisors's 13F filing for Q4 2020, filed 9 Feb 2021.